Back to VRDN

Venrock Adviser, LLC → VRDN

Venrock Adviser, LLC VRDN Position History

Viridian Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$67.1M
Q3 2026
Peak value
$120.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$120.8M
Q1 2026$75.9M
Q2 2026$59.8M
Q3 2026$67.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$67.1M3.26M——
Q2 2026$59.8M3.26M——
Q1 2026$75.9M3.88M——
Q4 2025$120.8M3.88M——

Other funds holding VRDN

Other Venrock Adviser, LLC positions

APGE

APOGEE THERAPEUTICS INC

$1.1B
APGE

APOGEE THERAPEUTICS INC

$714.9M
APGE

APOGEE THERAPEUTICS INC

$641.1M
ORKA

ORUKA THERAPEUTICS INC

$394.8M
ORKA

ORUKA THERAPEUTICS INC

$345.5M
EQR

ERASCA INC

$327.8M
EQR

ERASCA INC

$294.5M
EQR

ERASCA INC

$265.1M